{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:45:43Z","timestamp":1790783143474,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T00:00:00Z","timestamp":1709769600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR grant RA-COVID-19"],"award-info":[{"award-number":["ANR grant RA-COVID-19"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Thrombo-inflammation and neutrophil extracellular traps (NETs) are exacerbated in severe cases of COVID-19, potentially contributing to disease exacerbation. However, the mechanisms underpinning this dysregulation remain elusive. We hypothesised that lower DNase activity may be associated with higher NETosis and clinical worsening in patients with COVID-19.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Biological samples were obtained from hospitalized patients (15 severe, 37 critical at sampling) and 93 non-severe ambulatory cases. Our aims were to compare NET biomarkers, functional DNase levels, and explore mechanisms driving any imbalance concerning disease severity.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Functional DNase levels were diminished in the most severe patients, paralleling an imbalance between NET markers and DNase activity. DNase1 antigen levels were higher in ambulatory cases but lower in severe patients. DNase1L3 antigen levels remained consistent across subgroups, not rising alongside NET markers. <jats:italic>DNASE1<\/jats:italic> polymorphisms correlated with reduced DNase1 antigen levels. Moreover, a quantitative deficiency in plasmacytoid dendritic cells (pDCs), which primarily express <jats:italic>DNase1L3<\/jats:italic>, was observed in critical patients. Analysis of public single-cell RNAseq data revealed reduced <jats:italic>DNase1L3<\/jats:italic> expression in pDCs from severe COVID-19 patient.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Severe and critical COVID-19 cases exhibited an imbalance between NET and DNase functional activity and quantity. Early identification of NETosis imbalance could guide targeted therapies against thrombo-inflammation in COVID-19-related sepsis, such as DNase administration, to avert clinical deterioration.<\/jats:p>\n                <jats:p><jats:italic>Trial registration<\/jats:italic>: COVERAGE trial (NCT04356495) and COLCOV19-BX study (NCT04332016).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12967-024-05044-7","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:15:33Z","timestamp":1709813733000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Impaired balance between neutrophil extracellular trap formation and degradation by DNases in COVID-19 disease"],"prefix":"10.1186","volume":"22","author":[{"given":"Geoffrey","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Labrouche-Colomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Duvignaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Clequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Dussiau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David-Alexandre","family":"Tr\u00e9gou\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Malvy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Prevel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atika","family":"Zouine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Pellegrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Goret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mamani-Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1112-4845","authenticated-orcid":false,"given":"Antoine","family":"Dewitte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,7]]},"reference":[{"issue":"9","key":"5044_CR1","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1016\/S1473-3099(20)30484-9","volume":"20","author":"E Petersen","year":"2020","unstructured":"Petersen E, et al. Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics. Lancet Infect Dis. 2020;20(9):e238\u201344.","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"5044_CR2","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1001\/jama.2020.12839","volume":"324","author":"WJ Wiersinga","year":"2020","unstructured":"Wiersinga WJ, et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. JAMA. 2020;324(8):782.","journal-title":"JAMA"},{"issue":"8","key":"5044_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu N, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727\u201333.","journal-title":"N Engl J Med"},{"key":"5044_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669","author":"Acute Respiratory Distress Syndrome","year":"2012","unstructured":"Acute Respiratory Distress Syndrome. The Berlin definition. JAMA. 2012. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"issue":"7","key":"5044_CR5","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"5044_CR6","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S2213-2600(20)30316-7","volume":"8","author":"C Karagiannidis","year":"2020","unstructured":"Karagiannidis C, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8(9):853\u201362.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5044_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13073-023-01173-8","volume":"15","author":"D Matuozzo","year":"2023","unstructured":"Matuozzo D, et al. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19. Genome Med. 2023;15(1):22.","journal-title":"Genome Med"},{"issue":"6515","key":"5044_CR8","doi-asserted-by":"publisher","first-page":"eabd4585","DOI":"10.1126\/science.abd4585","volume":"370","author":"P Bastard","year":"2020","unstructured":"Bastard P, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science. 2020;370(6515):eabd4585.","journal-title":"Science"},{"issue":"5","key":"5044_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","volume":"20","author":"MM Lamers","year":"2022","unstructured":"Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270\u201384.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"5044_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5):319\u201329.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"5044_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol. 2013;13(1):34\u201345.","journal-title":"Nat Rev Immunol"},{"issue":"5663","key":"5044_CR12","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann V, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532\u20135.","journal-title":"Science"},{"issue":"6367","key":"5044_CR13","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1126\/science.aam8897","volume":"358","author":"M Jim\u00e9nez-Alc\u00e1zar","year":"2017","unstructured":"Jim\u00e9nez-Alc\u00e1zar M, et al. Host DNases prevent vascular occlusion by neutrophil extracellular traps. Science. 2017;358(6367):1202\u20136.","journal-title":"Science"},{"issue":"9","key":"5044_CR14","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1161\/ATVBAHA.119.312463","volume":"39","author":"T Charlotte","year":"2019","unstructured":"Charlotte T, et al. Neutrophil extracellular traps. Arterioscler Thromb Vasc Biol. 2019;39(9):1724\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"5044_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","volume":"127","author":"JD McFadyen","year":"2020","unstructured":"McFadyen JD, Stevens H, Peter K. The emerging threat of (micro) thrombosis in COVID-19 and its therapeutic implications. Circ Res. 2020;127(4):571\u201387.","journal-title":"Circ Res"},{"key":"5044_CR16","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.150111","author":"Y Zuo","year":"2021","unstructured":"Zuo Y, et al. Autoantibodies stabilize neutrophil extracellular traps in COVID-19. JCI Insight. 2021. https:\/\/doi.org\/10.1172\/jci.insight.150111.","journal-title":"JCI Insight"},{"issue":"10","key":"5044_CR17","doi-asserted-by":"publisher","first-page":"e043790","DOI":"10.1136\/bmjopen-2020-043790","volume":"11","author":"Q Wang","year":"2021","unstructured":"Wang Q, et al. Clinical value of laboratory indicators for predicting disease progression and death in patients with COVID-19: a retrospective cohort study. BMJ Open. 2021;11(10):e043790.","journal-title":"BMJ Open"},{"issue":"11","key":"5044_CR18","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","volume":"199","author":"O Roca","year":"2019","unstructured":"Roca O, et al. An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med. 2019;199(11):1368\u201376.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"5044_CR19","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration","year":"2021","unstructured":"Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904\u201316.","journal-title":"Nat Med"},{"key":"5044_CR20","doi-asserted-by":"publisher","first-page":"851497","DOI":"10.3389\/fimmu.2022.851497","volume":"13","author":"R Pr\u00e9vel","year":"2022","unstructured":"Pr\u00e9vel R, et al. Plasma markers of neutrophil extracellular trap are linked to survival but not to pulmonary embolism in COVID-19-related ARDS patients. Front Immunol. 2022;13:851497.","journal-title":"Front Immunol"},{"key":"5044_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.cca.2016.05.029","volume":"459","author":"S Masuda","year":"2016","unstructured":"Masuda S, et al. NETosis markers: quest for specific, objective, and quantitative markers. Clin Chim Acta. 2016;459:89\u201393.","journal-title":"Clin Chim Acta"},{"issue":"16","key":"5044_CR22","doi-asserted-by":"publisher","first-page":"e160332","DOI":"10.1172\/jci.insight.160332","volume":"7","author":"C Carmona-Rivera","year":"2022","unstructured":"Carmona-Rivera C, et al. Multicenter analysis of neutrophil extracellular trap dysregulation in adult and pediatric COVID-19. JCI Insight. 2022;7(16):e160332.","journal-title":"JCI Insight"},{"issue":"12","key":"5044_CR23","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1016\/j.immuni.2022.11.007","volume":"55","author":"IV Aramburu","year":"2022","unstructured":"Aramburu IV, et al. Functional proteomic profiling links deficient DNA clearance with increased mortality in individuals with severe COVID-19 pneumonia. Immunity. 2022;55(12):2436-2453.e5.","journal-title":"Immunity"},{"issue":"6","key":"5044_CR24","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/SHK.0000000000001804","volume":"56","author":"S Sohrabipour","year":"2021","unstructured":"Sohrabipour S, et al. Mechanistic studies of DNase I activity: impact of heparin variants and PAD4. Shock. 2021;56(6):975\u201387.","journal-title":"Shock"},{"issue":"1","key":"5044_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12871-019-0911-7","volume":"20","author":"LE Cox","year":"2020","unstructured":"Cox LE, et al. Neutrophil extracellular trap formation and nuclease activity in septic patients. BMC Anesthesiol. 2020;20(1):15.","journal-title":"BMC Anesthesiol"},{"issue":"4","key":"5044_CR26","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1111\/j.1742-4658.2008.06849.x","volume":"276","author":"M Napirei","year":"2009","unstructured":"Napirei M, et al. Murine serum nucleases \u2013 contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). FEBS J. 2009;276(4):1059\u201373.","journal-title":"FEBS J"},{"issue":"3","key":"5044_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1042\/bj20040046","volume":"380","author":"M Napirei","year":"2004","unstructured":"Napirei M, et al. Expression pattern of the deoxyribonuclease 1 gene: lessons from the Dnase1 knockout mouse. Biochemical Journal. 2004;380(3):929\u201337.","journal-title":"Biochemical Journal"},{"issue":"1","key":"5044_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.cell.2016.05.034","volume":"166","author":"V Sisirak","year":"2016","unstructured":"Sisirak V, et al. Digestion of chromatin in apoptotic cell microparticles prevents autoimmunity. Cell. 2016;166(1):88\u2013101.","journal-title":"Cell"},{"issue":"4","key":"5044_CR29","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.immuni.2020.07.026","volume":"53","author":"R Zhou","year":"2020","unstructured":"Zhou R, et al. Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses. Immunity. 2020;53(4):864-877.e5.","journal-title":"Immunity"},{"issue":"12","key":"5044_CR30","doi-asserted-by":"publisher","first-page":"6290","DOI":"10.1172\/JCI140335","volume":"130","author":"I S\u00e1nchez-Cerrillo","year":"2020","unstructured":"S\u00e1nchez-Cerrillo I, et al. COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes. J Clin Investig. 2020;130(12):6290\u2013300.","journal-title":"J Clin Investig"},{"issue":"4","key":"5044_CR31","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/imm.13254","volume":"161","author":"B Peruzzi","year":"2020","unstructured":"Peruzzi B, et al. Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020;161(4):345\u201353.","journal-title":"Immunology"},{"issue":"10","key":"5044_CR32","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1038\/s41591-020-1038-6","volume":"26","author":"AG Laing","year":"2020","unstructured":"Laing AG, et al. A dynamic COVID-19 immune signature includes associations with poor prognosis. Nat Med. 2020;26(10):1623\u201335.","journal-title":"Nat Med"},{"issue":"5","key":"5044_CR33","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41556-021-00681-2","volume":"23","author":"M Saichi","year":"2021","unstructured":"Saichi M, et al. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol. 2021;23(5):538\u201351.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"5044_CR34","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1002\/iid3.402","volume":"9","author":"A Kulkarni-Munje","year":"2021","unstructured":"Kulkarni-Munje A, et al. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity. Immunity Inflam Dis. 2021;9(2):419\u201334.","journal-title":"Immunity Inflam Dis"},{"issue":"9","key":"5044_CR35","doi-asserted-by":"publisher","first-page":"e1009878","DOI":"10.1371\/journal.ppat.1009878","volume":"17","author":"M Severa","year":"2021","unstructured":"Severa M, et al. Differential plasmacytoid dendritic cell phenotype and type I interferon response in asymptomatic and severe COVID-19 infection. PLoS Pathog. 2021;17(9):e1009878.","journal-title":"PLoS Pathog"},{"key":"5044_CR36","doi-asserted-by":"publisher","first-page":"1181761","DOI":"10.3389\/fimmu.2023.1181761","volume":"14","author":"H Englert","year":"2023","unstructured":"Englert H, et al. Targeting NETs using dual-active DNase1 variants. Front Immunol. 2023;14:1181761.","journal-title":"Front Immunol"},{"issue":"18","key":"5044_CR37","doi-asserted-by":"publisher","first-page":"eabc1518","DOI":"10.1126\/sciadv.abc1518","volume":"6","author":"JS Ayres","year":"2020","unstructured":"Ayres JS. Surviving COVID-19: a disease tolerance perspective. Sci Adv. 2020;6(18):eabc1518.","journal-title":"Sci Adv"},{"key":"5044_CR38","doi-asserted-by":"publisher","first-page":"714833","DOI":"10.3389\/fimmu.2021.714833","volume":"12","author":"ZM Holliday","year":"2021","unstructured":"Holliday ZM, et al. Non-randomized trial of dornase alfa for acute respiratory distress syndrome secondary to covid-19. Front Immunol. 2021;12:714833.","journal-title":"Front Immunol"},{"issue":"9","key":"5044_CR39","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1016\/j.jtha.2023.02.033","volume":"21","author":"N Krinsky","year":"2023","unstructured":"Krinsky N, et al. NETosis induction reflects COVID-19 severity and long COVID: insights from a 2-center patient cohort study in Israel. J Thromb Haemost. 2023;21(9):2569\u201384.","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5044_CR40","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12931-023-02336-2","volume":"24","author":"FP Veras","year":"2023","unstructured":"Veras FP, et al. Targeting neutrophils extracellular traps (NETs) reduces multiple organ injury in a COVID-19 mouse model. Respir Res. 2023;24(1):66.","journal-title":"Respir Res"},{"issue":"7","key":"5044_CR41","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.cmi.2022.02.031","volume":"28","author":"A Duvignaud","year":"2022","unstructured":"Duvignaud A, et al. Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE). Clin Microbiol Infect. 2022;28(7):1010\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"5044_CR42","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1186\/s13063-020-04619-1","volume":"21","author":"A Duvignaud","year":"2020","unstructured":"Duvignaud A, et al. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): a structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial). Trials. 2020;21(1):846.","journal-title":"Trials"},{"key":"5044_CR43","volume-title":"Clinical management of COVID-19: living guideline","author":"WHO","year":"2022","unstructured":"WHO. Clinical management of COVID-19: living guideline. Geneva: World Health Organization; 2022."},{"issue":"7","key":"5044_CR44","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/BF01709751","volume":"22","author":"J-L Vincent","year":"1996","unstructured":"Vincent J-L, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction\/failure: on behalf of the working group on sepsis-related problems of the european society of intensive care medicine (see contributors to the project in the appendix). Intensive Care Med. 1996;22(7):707\u201310.","journal-title":"Intensive Care Med"},{"issue":"11","key":"5044_CR45","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1097\/00003246-198411000-00012","volume":"12","author":"J-RL Gall","year":"1984","unstructured":"Gall J-RL, et al. A simplified acute physiology score for ICU patients. Crit Care Med. 1984;12(11):975\u20137.","journal-title":"Crit Care Med"},{"issue":"8","key":"5044_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801.","journal-title":"JAMA"},{"issue":"3","key":"5044_CR47","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s12026-017-8905-3","volume":"65","author":"C Th\u00e5lin","year":"2017","unstructured":"Th\u00e5lin C, et al. Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma. Immunol Res. 2017;65(3):706\u201312.","journal-title":"Immunol Res"},{"issue":"10","key":"5044_CR48","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.1111\/jth.15003","volume":"18","author":"C Th\u00e5lin","year":"2020","unstructured":"Th\u00e5lin C, et al. Quantification of citrullinated histones: development of an improved assay to reliably quantify nucleosomal H3Cit in human plasma. J Thromb Haemost. 2020;18(10):2732\u201343.","journal-title":"J Thromb Haemost"},{"issue":"3","key":"5044_CR49","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/cyto.a.24269","volume":"99","author":"F Mair","year":"2021","unstructured":"Mair F, Liechti T. Comprehensive phenotyping of human dendritic cells and monocytes. Cytometry Pt A. 2021;99(3):231\u201342.","journal-title":"Cytometry Pt A"},{"key":"5044_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1007\/s11222-012-9343-7","volume":"23","author":"Y Zhang","year":"2013","unstructured":"Zhang Y. Likelihood-based and Bayesian methods for Tweedie compound Poisson linear mixed models. Stat Comput. 2013;23:743\u201357.","journal-title":"Stat Comput"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05044-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05044-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05044-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,10]],"date-time":"2024-03-10T15:02:56Z","timestamp":1710082976000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05044-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["5044"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05044-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]},"assertion":[{"value":"14 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"246"}}